期刊文献+

K562/NOD-SCID小鼠白血病模型的建立 被引量:15

Establishment of K562/NOD-SCID Mouse Model with Leukemia
暂未订购
导出
摘要 本研究探讨人CML急性变的白血病细胞在NOD-SCID小鼠体内建立白血病模型的方法并研究其生长特性。首先将K562细胞接种于全身受照射后的裸鼠,待皮下成瘤后取出局部瘤块,选取无坏死的瘤组织制成瘤细胞悬液,再腹腔接种于全身受照射后的NOD-SCID小鼠。结果表明:成功建立全身播散的白血病模型,4周时外周血涂片可见白血病细胞,晚期浸润肝、脾、骨髓等造血器官,白细胞上升到接种前的8-10倍,血涂片中白血病细胞达20%-30%。腹腔局部出现瘤块,多位于腹腔内或大网膜,较少累及其他器官。结论:腹腔接种K562瘤细胞于全身照射后的NOD-SCID小鼠能建成全身播散的白血病模型,该模型较好地反映白血病在体内的演变过程,是进行新药疗效试验、生物导向治疗及基因治疗的理想工具。 The study was aimed to establish a K562/NOD-SCID leukemia mouse model and to explore its growth characteristics. Nude mice exposed to total body irradiation were inoculated subeutaneouly with K562 cells, then the local K562 tumor was taken out and the tumor tissues nithout necoosis were selected for preparing single cell suspension which was inoculated into irradiated NOD/SCID mice by intraperitoneal injection. The results indicated that the systemic disseminated leukemia model was established successfully by intraparitoneal injection. On the fourth week after inoculation the leukemia cells were found on peripheral blood smear, and the leukemia cell infiltration was observed in liver, spleen and bone marrow. On the brink of death, the count of peripheral blood WBC was 8 - 10 times as much as that before inoculation. The leukemia cells on peripheral blood smear acounted to 20% -30% of the total WBCs on average. The local tumors appeared in the abdominal cavity or on the greater omentum, less were involved in other organs. It is concluded that the established K562/NOD-SCID mouse model with leukemia well imitates the process of leukemia in human body, so it is a good model for the research on the effects of new drugs and target or gene therapy.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第1期16-19,共4页 Journal of Experimental Hematology
关键词 K562细胞 NOD—SCID小鼠 白血病模型 K562 cell NOD-SCID mouse leukemia model
  • 相关文献

参考文献5

二级参考文献24

  • 1陈国强,朱军,陈竺,王振义.SCID小鼠-人类白血病模型及其应用[J].国外医学(输血及血液学分册),1995,18(1):29-32. 被引量:2
  • 2Miyagi T, Kubonishi I, Ohtsuki Y, et al. Direct and serial transplantation of Ph1-positive acute lymphoblastic leukemia into nude mice[J]. Int J Cancer,1989, 43(6):1149-1154.
  • 3Potter GK, Shen RN, Chiao JW. Nude mice as models for human leukemia studies[J]. Am J Pathol,1984, 114(3):360-366.
  • 4Vey N, Giles FJ, Kantarjian H, et al. The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia[J]. Clin Cancer Res,2000, 6(2):731-736.
  • 5Schuler W, Weiler IJ, Schuler A, et al. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. [J]Cell,1986, 46(7):963-972.
  • 6Dorshkind K, Pollack SB, Bosma MJ, et al. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid)[J]. J Immunol,1985, 134(6):3798-3801.
  • 7De Lord C, Clutterbuck R, Titley J, et al. Growth of primary human acute leukemia in severe combined immunodeficient mice[J]. Exp Hematol,1991, 19(9):991-993.
  • 8Arai C, Tsuzaki Y, Arai N, et al. Establishment of an in vivo human myeloid leukemia model in the SCID mouse[J]. In Vivo,1999, 13(1):35-40.
  • 9Bosma GC,Custer RP,Bosma MJ,et al.A severe combined immunodeficiency mutation in the mouse[J].Nature,1983, 301(4):527-530.
  • 10Gallagher R , Collins S, Trujillo J, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia[J]. Blood, 1979, 54(3): 713-733.

共引文献30

同被引文献178

引证文献15

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部